LNTH - Lantheus Holdings, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
55.35 1.17 (2.12%) --- --- 0.0 (0.0%) 0.0 (0.0%) 1.16 (2.1%) 0.0 (0.01%) 0.0 (0.01%)

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Category: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market Period: Closed

Earnings & Ratios

Basic EPS:
1.15
Diluted EPS:
1.12
Basic P/E:
49.1518
Diluted P/E:
50.4684
RSI(14) 1m:
100.0
VWAP:
56.52
RVol:
0.9459

Events

Period Kind Movement Occurred At

Related News